Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.

Abstract:

OBJECTIVES:The aim of this study was to investigate the association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function. METHODS:Liver biopsy was performed for 30 patients with hepatitis B cirrhosis to test the content of hydroxyproline in hepatic tissue, judge the degree of cirrhosis and determine the Laennec staging system. The association of the Laennec staging system with the degree of cirrhosis, clinical stage and liver function was compared. RESULTS:The Laennec staging system had a close association with clinical stage, model for end-stage liver disease score and degree of cirrhosis (r = 0.58, p < 0.01; r = 0.60, p < 0.01; r = 0.53, p < 0.01). CONCLUSIONS:The Laennec histological grading system can to some extent reflect the degree of cirrhosis, clinical stage and liver function, and is expected to predict the incidence of patient complications in a useful way.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Wang W,Li J,Pan R,A S,Liao C

doi

10.1007/s12072-015-9648-7

subject

Has Abstract

pub_date

2015-10-01 00:00:00

pages

621-6

issue

4

eissn

1936-0533

issn

1936-0541

pii

10.1007/s12072-015-9648-7

journal_volume

9

pub_type

杂志文章
  • A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients.

    abstract:PURPOSE:Clevudine 30 mg showed potent antiviral activity with a marked post-treatment antiviral effect. However, long-term treatment with clevudine monotherapy induced resistance and myopathy in some cases. The objective of this study is to evaluate the preliminary efficacy and safety of the combination of clevudine 20...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-014-9537-5

    authors: Tak WY,Yang JM,Kim BI,Baik SK,Cheon GJ,Byun KS,Kim DY,Yoo BC

    更新日期:2014-05-25 00:00:00

  • Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay.

    abstract:BACKGROUND:Possible serologic activity after hepatitis B surface antigen (HBsAg) seroclearance documented by conventional assays in chronic hepatitis B (CHB) has not been thoroughly investigated. METHODS:We determined the levels of serum hepatitis B virus (HBV) DNA, hepatitis B core-related antigen (HBcrAg), and linea...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-012-9354-7

    authors: Seto WK,Tanaka Y,Wong DK,Lai CL,Shinkai N,Yuen JC,Tong T,Fung J,Hung IF,Yuen MF

    更新日期:2012-03-13 00:00:00

  • Biology of portal hypertension.

    abstract::Portal hypertension develops as a result of increased intrahepatic vascular resistance often caused by chronic liver disease that leads to structural distortion by fibrosis, microvascular thrombosis, dysfunction of liver sinusoidal endothelial cells (LSECs), and hepatic stellate cell (HSC) activation. While the basic ...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-017-9826-x

    authors: McConnell M,Iwakiri Y

    更新日期:2018-02-01 00:00:00

  • Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2.

    abstract:BACKGROUND:The life cycle of hepatitis C virus (HCV) is tightly associated with host lipoprotein metabolic pathways. Apolipoprotein is present on the outer surface of lipoprotein particles and plays an important role in lipoprotein metabolism. We aimed to elucidate the influence of chronic HCV infection on serum apolip...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-014-9572-2

    authors: Seki N,Sugita T,Aida Y,Itagaki M,Ishiguro H,Sutoh S,Abe H,Tsubota A,Matsushima M,Aizawa Y

    更新日期:2014-10-01 00:00:00

  • Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

    abstract:BACKGROUND:Initial presentation of hepatocellular carcinoma (HCC) at an advanced stage in patients under a regular surveillance program is a devastating problem. AIMS:We assessed the prevalence and factors associated with this surveillance failure. METHODS:A total of 304 HCC patients who received regular surveillance...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9462-z

    authors: Sinn DH,Yi J,Choi MS,Choi D,Gwak GY,Paik YH,Lee JH,Koh KC,Paik SW,Yoo BC

    更新日期:2013-10-01 00:00:00

  • Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis.

    abstract:BACKGROUND:L-Asparaginase is a bacterial enzyme used in the treatment of acute lymphoblastic leukemia. In the ongoing U.S. Drug-Induced Liver Injury Network (DILIN) prospective study, standard and pegylated asparaginase were the most frequent cause of liver injury with jaundice among anti-cancer agents (8 of 40: 20%). ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-019-09971-2

    authors: Kamal N,Koh C,Samala N,Fontana RJ,Stolz A,Durazo F,Hayashi PH,Phillips E,Wang T,Hoofnagle JH,Drug-Induced Liver Injury Network.

    更新日期:2019-09-01 00:00:00

  • Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease.

    abstract:BACKGROUND:Although arterial stiffness has been reported to be associated with nonalcoholic fatty liver disease (NAFLD), previous studies have relied only on noninvasive assessments for the diagnosis of NAFLD. This study attempted to investigate the association of arterial stiffness with the histological severity of NA...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-020-10108-z

    authors: Kim HL,Koo BK,Joo SK,Kim W

    更新日期:2020-12-01 00:00:00

  • A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review.

    abstract::To address the relationship between hepatitis B virus (HBV) endemicity and HBV-related liver diseases in Mexico. Research literature reporting on HBsAg and antibody to hepatitis B core antigen (anti-HBc) prevalence in Mexican study groups were searched in NLM Gateway, PubMed, IMBIOMED, and others. Weighted mean preval...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9115-9

    authors: Roman S,Panduro A,Aguilar-Gutierrez Y,Maldonado M,Vazquez-Vandyck M,Martinez-Lopez E,Ruiz-Madrigal B,Hernandez-Nazara Z

    更新日期:2009-06-01 00:00:00

  • Cirrhotic cardiomyopathy.

    abstract::Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation, and electrophysiological abnormalities in the absence of any known cardiac disease. It can be diagnosed by using a combi...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9109-7

    authors: Wong F

    更新日期:2009-03-01 00:00:00

  • Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment.

    abstract:OBJECTIVE:Type II mixed cryoglobulinemia (MC) is a systemic vasculitis usually associated with hepatitis C virus (HCV). The present trial was performed to investigate the efficacy of therapy with pegylated interferon alfa-2a (PEG-IFN alfa-2a) plus ribavirin in patients with HCV-related MC vasculitis and evaluate the fa...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-011-9303-x

    authors: El Khayat HR,Fouad YM,Ahmad EA,El Amin H,Ismael F,Rizk A

    更新日期:2012-06-01 00:00:00

  • Pharmacologic prevention of variceal bleeding and rebleeding.

    abstract:BACKGROUND:Variceal bleeding is a major complication of portal hypertension, which is associated with significant mortality. Moreover, patients surviving a variceal bleeding episode have very high risk of rebleeding, which is associated with mortality as high as that of the first bleed. Because of this, prevention of b...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-017-9833-y

    authors: Baiges A,Hernández-Gea V,Bosch J

    更新日期:2018-02-01 00:00:00

  • Obstructive jaundice promotes intestinal-barrier dysfunction and bacterial translocation: experimental study.

    abstract:BACKGROUND:Although clinical and experimental studies have demonstrated a correlation between obstructive jaundice and the development of sepsis, the mechanism has not been fully elucidated. PURPOSE:The aim of this study was to investigate the influence of biliary obstruction on bacterial translocation as a possible s...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-007-9018-1

    authors: Abdeldayem H,Ghoneim E,Refaei AA,Abou-Gabal A

    更新日期:2007-12-01 00:00:00

  • The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis.

    abstract:BACKGROUND AND OBJECT:The risk of occult HBV infection (OBI) in children whose mothers are HBV carriers has received more widespread attention, but there were few reports to focus on the children with HBsAg-positive parents. In this study, we aimed to investigate the prevalence of OBI in immunized children with HBsAg-p...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-020-10055-9

    authors: Zhuge S,Ge C,Yang Y,Cui Y,Yue X,Zhang Z,Xu H,Huang A,Zhao Y

    更新日期:2020-07-01 00:00:00

  • Hepatitis B reactivation after chemotherapy: two decades of clinical research.

    abstract::Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this important clinical problem has been made in the past 2 decades. By ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9056-3

    authors: Lau GK

    更新日期:2008-06-01 00:00:00

  • An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

    abstract:AIM:Tamibarotene is a synthetic retinoid expected to inhibit tumor-cell proliferation and to induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an open-label phase I/II study to determine the maximum tolerated dose (MTD) and recommended dose (RD), and to evaluate the pharmacokinetic...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9459-7

    authors: Kanai F,Obi S,Fujiyama S,Shiina S,Tamai H,Mochizuki H,Koike Y,Imamura J,Yamaguchi T,Saida I,Yokosuka O,Omata M

    更新日期:2014-01-01 00:00:00

  • The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH).

    abstract:BACKGROUND AND AIMS:The peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, piglitazone, enhances the degradation of branched-chain amino acids (BCAAs) in adipose tissue. However, it remains unknown whether pioglitazone influences the plasma amino acids (AA) profile in patients with nonalcoholic steatohepatit...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-012-9395-y

    authors: Kakazu E,Kondo Y,Ninomiya M,Kimura O,Nagasaki F,Ueno Y,Shimosegawa T

    更新日期:2013-06-01 00:00:00

  • Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

    abstract::Substantial advancements in the field of primary biliary cirrhosis (PBC) research have broadened our understanding of this enigmatic disease. Genome-wide studies have identified several new candidate genes involved in the immunoregulatory process, particularly those responsible for antigen presentation and lymphocyte ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-012-9362-7

    authors: Trivedi PJ,Cullen S

    更新日期:2013-03-01 00:00:00

  • The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

    abstract:GOALS:The aim of our study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) and advanced hepatic fibrosis in patients with type 1 diabetes (T1D) using simple noninvasive scores. BACKGROUND:There is paucity of data on the prevalence of NAFLD in T1D. Moreover, T1D could be a risk factor for advanc...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-017-9840-z

    authors: Singh A,Le P,Lopez R,Alkhouri N

    更新日期:2018-01-01 00:00:00

  • Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?

    abstract::The cancer stem cell (CSC) hypothesis has been disproved in many cancers. CSCs may exist in blood cancer, while many epithelial cancers may not have CSCs but tumor-initiating cells (TICs). Several independent studies have provided strong evidence for existence of CSCs in brain, skin, and colon cancers (Mani et al. in ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-016-9777-7

    authors: Machida K

    更新日期:2017-03-01 00:00:00

  • Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.

    abstract:BACKGROUND AND AIM:Relationships between circulating microRNA-122 (miR-122) and histological features of nonalcoholic fatty liver disease (NAFLD) are unclear. METHODS:The impact of serum miR-122 levels for histological features and hepatocellular carcinoma (HCC) was investigated in 305 Japanese patients with histologi...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-016-9729-2

    authors: Akuta N,Kawamura Y,Suzuki F,Saitoh S,Arase Y,Kunimoto H,Sorin Y,Fujiyama S,Sezaki H,Hosaka T,Kobayashi M,Suzuki Y,Kobayashi M,Ikeda K,Kumada H

    更新日期:2016-07-01 00:00:00

  • Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients.

    abstract:BACKGROUND AND AIMS:Coagulopathic bleeding risk prediction is challenging in decompensated cirrhosis (DC) by conventional assays. Viscoelastic tests (VETs) are likely to be more useful for assessing coagulation status in these patients. We investigated whether the VET (Sonoclot) parameters with fibrinogen could predict...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-020-10036-y

    authors: Bihari C,Patil A,Shasthry SM,Baweja S,Kumar G,Sarin SK

    更新日期:2020-07-01 00:00:00

  • MSC-based therapies in solid organ transplantation.

    abstract::Immunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression su...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9509-1

    authors: Benseler V,Obermajer N,Johnson CL,Soeder Y,Dahlke MD,Popp FC

    更新日期:2014-04-01 00:00:00

  • Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries.

    abstract:PURPOSE:The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party to develop a consensus cost-effectiveness model for treatment of Hepatitis B in Asia Pacific countries in March 2010. METHODS:The working party consisted of expert hepatologists, virologists and epidemiolog...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-014-9549-1

    authors: Dan YY,Wong JB,Hamid SS,Han KH,Jia JD,Liu CJ,Piratvisuth T,Lok AS,Lim SG

    更新日期:2014-07-01 00:00:00

  • Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.

    abstract::The prognosis of advanced hepatocellular carcinoma (HCC) remains poor. For patients with advanced HCC, the multikinase inhibitor sorafenib is recommended as the current standard of care. In contrast, hepatic arterial infusion chemotherapy (HAIC) is one of the recommended treatments in Japan. However, in Japan, the use...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9515-3

    authors: Yamasaki T,Saeki I,Sakaida I

    更新日期:2014-09-01 00:00:00

  • Management of primary sclerosing cholangitis and its complications: an algorithmic approach.

    abstract::Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterized by multiple strictures and dilatations of the intra- and extrahepatic bile ducts, leading to progressive liver fibrosis, in 10-15% cholangiocarcinoma, and ultimately end-stage liver disease. The pathogenesis is poorly understood, b...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-020-10118-x

    authors: Prokopič M,Beuers U

    更新日期:2020-12-30 00:00:00

  • Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

    abstract::Non-alcoholic fatty liver disease (NAFLD) is currently one of the leading forms of chronic liver disease, and its rising frequency worldwide has reached epidemic proportions. NAFLD, particularly its progressive variant NASH (non-alcoholic steatohepatitis), can lead to advanced fibrosis, cirrhosis, and HCC. The pathoph...

    journal_title:Hepatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s12072-018-9854-1

    authors: Kovalic AJ,Satapathy SK,Chalasani N

    更新日期:2018-03-01 00:00:00

  • Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation.

    abstract::Spontaneous bacterial peritonitis (SBP) is a common cause of morbidity and mortality in patients with advanced cirrhosis and portal hypertension. While gram-negative rods and Enterococcus species are the common offending organisms, Salmonella has also been recognized as a rare and atypical offending organism. Atypical...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9087-9

    authors: Rajekar H,Wai CT,Lee KH,Wong SY,Tan KC

    更新日期:2008-09-01 00:00:00

  • A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients.

    abstract:PURPOSE:To compare the efficacy of entecavir (ETV) monotherapy up to 4 years in nucleos(t)ide analog (NA)-experienced and -naïve subjects. METHODS:One hundred sixty NA-experienced and 282 naïve chronic hepatitis B patients who were treated with ETV were enrolled. Of the 160 NA-experienced patients, 49 had prior lamivu...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-013-9440-5

    authors: Chen CH,Hu TH,Hung CH,Lu SN,Wang JH,Chang MH,Changchien CS,Lee CM

    更新日期:2013-07-01 00:00:00

  • Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

    abstract::Background and aims The aims of this study were to evaluate a preventive effect on collateral venous circulation of long-term administration of propranolol in intrahepatic portal hypertensive rats. Methods Eighty-six Sprague-Dawley rats were allocated to two models of hepatic fibrosis, bile duct-ligated (BDL) induced ...

    journal_title:Hepatology international

    pub_type: 杂志文章

    doi:10.1007/s12072-008-9070-5

    authors: Fizanne L,Régenet N,Wang J,Oberti F,Moal F,Roux J,Gallois Y,Michalak S,Calès P

    更新日期:2008-12-01 00:00:00

  • Prednisolone plus S-adenosil-L-methionine in severe alcoholic hepatitis.

    abstract:PURPOSE/BACKGROUND:Severe alcoholic hepatitis (AH) is a life-threatening liver disease with a potential of 30-40 % mortality at 1 month. While steroids remain to be a first line therapy, they provide only about 50 % survival benefit. The aim of the study was to evaluate the efficacy of glucocorticoids plus S-adenosylme...

    journal_title:Hepatology international

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s12072-016-9751-4

    authors: Tkachenko P,Maevskaya M,Pavlov A,Komkova I,Pavlov C,Ivashkin V

    更新日期:2016-11-01 00:00:00